No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological* / adverse effects
-
Female
-
Humans
-
Ipilimumab / therapeutic use
-
Melanoma* / pathology
-
Neoplasms, Second Primary*
-
Nivolumab / therapeutic use
-
Pregnancy
-
Skin Neoplasms* / drug therapy
-
Skin Neoplasms* / pathology
Substances
-
Antineoplastic Agents, Immunological
-
Ipilimumab
-
Nivolumab